AnaptysBio Inc
ANAB
Market Cap$575.56M
Close$
$-14.56
174.3% downside
Current Fair Value
174.3% downsideOvervalued by 174.3% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $575.56 Million |
|---|---|
| Enterprise Value | $468.52 Million |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-5.12 |
| Beta | -0.2 |
| Outstanding Shares | 28,382,000 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -3.83 |
|---|---|
| PEG | 7.91 |
| Price to Sales | 6.53 |
| Price to Book Ratio | 9.8 |
| Enterprise Value to Revenue | 5.13 |
| Enterprise Value to EBIT | -4.25 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.03 |
| Debt to Equity | 0.23 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About AnaptysBio Inc
CEO: Hamza Suria